Further research on the association of irisin and vascular complications in pediatric patients with MetS and T2DM are needed, including in vitro and experimental models, to better clarify and understand the mechanisms underlying the pathophysiological role of irisin in these metabolic diseases. Here, FNDC5 is linked to metabolic syndrome.